↓ Skip to main content

Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible…

Overview of attention for article published in Stem Cell Research & Therapy, August 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes
Published in
Stem Cell Research & Therapy, August 2021
DOI 10.1186/s13287-021-02515-2
Pubmed ID
Authors

Saeed Oraee-Yazdani, Mohammadhosein Akhlaghpasand, Maryam Golmohammadi, Maryam Hafizi, Mina Soufi Zomorrod, Nima Mohseni Kabir, Maryam Oraee-Yazdani, Farzad Ashrafi, Alireza Zali, Masoud Soleimani

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 14%
Unspecified 3 11%
Student > Doctoral Student 2 7%
Student > Ph. D. Student 1 4%
Other 1 4%
Other 5 18%
Unknown 12 43%
Readers by discipline Count As %
Unspecified 3 11%
Biochemistry, Genetics and Molecular Biology 3 11%
Medicine and Dentistry 3 11%
Immunology and Microbiology 2 7%
Neuroscience 2 7%
Other 3 11%
Unknown 12 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2023.
All research outputs
#19,218,286
of 23,814,046 outputs
Outputs from Stem Cell Research & Therapy
#1,832
of 2,529 outputs
Outputs of similar age
#314,174
of 433,707 outputs
Outputs of similar age from Stem Cell Research & Therapy
#70
of 102 outputs
Altmetric has tracked 23,814,046 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,529 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one is in the 15th percentile – i.e., 15% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,707 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.